☆ 4.6 Letter

Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapseafter allogeneic haematopoietic cell transplantation inadults with inv(16) acute myeloid leukaemia

BRITISH JOURNAL OF HAEMATOLOGY (2018)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 180, Issue 3, Pages 448-451

Publisher

WILEY
DOI: 10.1111/bjh.14340

Keywords

acute myeloid leukaemia; CBFB-MYH11; minimal residual disease; allogeneic haematopoietic cell transplantation

Categories

Hematology

Funding

  1. Key Program of National Natural Science Foundation of China [81230013, 81530046]
  2. Health Science Promotion Project of Beijing [TG-2015-003]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.